Skip to main content
Premium Trial:

Request an Annual Quote

Bulldog Bio to Sell GeneWorks' Cloning Technology in US

NEW YORK (GenomeWeb News) – Bulldog Bio today said that it has been given the exclusive rights to sell Australian firm GeneWorks's Acquire PCR Cloning technology in the US.

"The technology incorporated into the Acquire PCR Cloning Kit will provide our customers with the potential for extraordinary results from both A-tailed and blunt-ended PCR products, without the need for color selection," Ella Fontaine, vice president of communication for Bulldog Bio, said in a statement. "The Acquire kit's novel feature set, including a unique vector with three base overhang, enables rapid and efficient cloning, and the attractive price should make it one of our most popular products."

Terms of the deal were not disclosed.

Bulldog, based in Portsmouth, NH, distributes tools to life science researchers. GeneWorks, headquartered in Adelaide, Australia, supplies molecular biology research products and services.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.